Harbor Capital Advisors Inc. Invests $1.94 Million in Oscar Health, Inc. (NYSE:OSCR)

Harbor Capital Advisors Inc. acquired a new stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 91,590 shares of the company's stock, valued at approximately $1,943,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Price T Rowe Associates Inc. MD raised its holdings in Oscar Health by 153.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company's stock valued at $59,156,000 after acquiring an additional 2,409,160 shares in the last quarter. First Light Asset Management LLC boosted its position in Oscar Health by 117.3% during the first quarter. First Light Asset Management LLC now owns 2,102,554 shares of the company's stock worth $31,265,000 after purchasing an additional 1,134,919 shares during the period. Renaissance Technologies LLC boosted its position in shares of Oscar Health by 31.7% in the second quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company's stock valued at $61,478,000 after acquiring an additional 934,600 shares during the period. Point72 Asset Management L.P. bought a new position in Oscar Health in the second quarter worth $14,716,000. Finally, Bank of New York Mellon Corp raised its stake in Oscar Health by 161.4% during the second quarter. Bank of New York Mellon Corp now owns 1,393,048 shares of the company's stock worth $22,038,000 after acquiring an additional 860,226 shares in the last quarter. Hedge funds and other institutional investors own 75.70% of the company's stock.

Analyst Ratings Changes

A number of research analysts recently weighed in on OSCR shares. UBS Group assumed coverage on Oscar Health in a report on Monday, October 7th. They set a "neutral" rating and a $23.00 target price on the stock. Piper Sandler restated an "overweight" rating and issued a $28.00 price target on shares of Oscar Health in a report on Tuesday, September 10th. Three analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Oscar Health currently has an average rating of "Moderate Buy" and an average target price of $24.00.

Insider Buying and Selling at Oscar Health

In other news, insider Mario Schlosser sold 3,198 shares of the firm's stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $57,532.02. Following the completion of the transaction, the insider now directly owns 76,982 shares of the company's stock, valued at $1,384,906.18. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other Oscar Health news, insider Mario Schlosser sold 3,198 shares of Oscar Health stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $57,532.02. Following the transaction, the insider now owns 76,982 shares in the company, valued at $1,384,906.18. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Alessandrea C. Quane sold 16,793 shares of Oscar Health stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $17.06, for a total value of $286,488.58. Following the sale, the executive vice president now directly owns 392,607 shares in the company, valued at $6,697,875.42. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 169,569 shares of company stock worth $3,007,069. Company insiders own 25.11% of the company's stock.

Oscar Health Price Performance

OSCR traded up $0.24 during midday trading on Tuesday, reaching $18.33. 5,200,394 shares of the company's stock were exchanged, compared to its average volume of 3,230,369. Oscar Health, Inc. has a 1-year low of $5.65 and a 1-year high of $23.79. The stock has a market capitalization of $4.43 billion, a PE ratio of -140.99, a P/E/G ratio of 34.96 and a beta of 1.67. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.91 and a quick ratio of 0.91. The business's 50-day moving average price is $18.74 and its 200 day moving average price is $18.43.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings results on Wednesday, August 7th. The company reported $0.20 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.16 by $0.04. The company had revenue of $2.20 billion for the quarter, compared to the consensus estimate of $2.13 billion. Oscar Health had a net margin of 0.25% and a return on equity of 1.86%. The company's revenue for the quarter was up 44.6% on a year-over-year basis. During the same period last year, the firm posted ($0.07) EPS. As a group, equities analysts anticipate that Oscar Health, Inc. will post 0.01 EPS for the current fiscal year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.